Pangea Bio
Louise T. is a Principal Research Scientist in Preclinical Development at Pangea Bio since January 2023 and previously held the role of Senior Research Scientist. Prior to this position, Louise T. worked at Trio Medicines LTD as a Senior Principal Scientist and Principal Scientist in Clinical Development from October 2020 to December 2022. Louise T. gained experience as a Postdoctoral Researcher in Molecular Imaging at Università degli Studi di Torino, focusing on the development of MRI Contrast Agents from December 2018 to October 2020. Louise T. completed a PhD in Biomedical Imaging at the University of Oxford between October 2014 and September 2018, after obtaining a Master of Chemistry with a focus on Medicinal Chemistry from the University of Warwick from 2010 to 2014. Additional experience includes a summer research project on photoactivatable metal complexes at the University of Warwick in August 2012.
Pangea Bio
Pangea develops transformative medicines for neurological disorders, deploying AI to uncover promising molecules from natural sources with prior evidence of efficacy and tolerability in humans based on traditional use.